| Vitamin D deficiency and risk of cardiovascular disease TJ Wang, MJ Pencina, SL Booth, PF Jacques, E Ingelsson, K Lanier, ... Circulation 117 (4), 503-511, 2008 | 3612 | 2008 |
| FGF23 induces left ventricular hypertrophy C Faul, AP Amaral, B Oskouei, MC Hu, A Sloan, T Isakova, OM Gutiérrez, ... The Journal of clinical investigation 121 (11), 2011 | 2376 | 2011 |
| Fibroblast growth factor 23 and mortality among patients undergoing hemodialysis OM Gutiérrez, M Mannstadt, T Isakova, JA Rauh-Hain, H Tamez, A Shah, ... New England Journal of Medicine 359 (6), 584-592, 2008 | 2137 | 2008 |
| Common genetic determinants of vitamin D insufficiency: a genome-wide association study TJ Wang, F Zhang, JB Richards, B Kestenbaum, JB Van Meurs, D Berry, ... The Lancet 376 (9736), 180-188, 2010 | 1933 | 2010 |
| Fibroblast growth factor 23 is elevated before parathyroid hormone and phosphate in chronic kidney disease T Isakova, P Wahl, GS Vargas, OM Gutiérrez, J Scialla, H Xie, D Appleby, ... Kidney international 79 (12), 1370-1378, 2011 | 1463 | 2011 |
| Prevalence of cardiovascular risk factors and the serum levels of 25-hydroxyvitamin D in the United States: data from the Third National Health and Nutrition Examination Survey D Martins, M Wolf, D Pan, A Zadshir, N Tareen, R Thadhani, A Felsenfeld, ... Archives of internal medicine 167 (11), 1159-1165, 2007 | 1324 | 2007 |
| Survival of patients undergoing hemodialysis with paricalcitol or calcitriol therapy M Teng, M Wolf, E Lowrie, N Ofsthun, JM Lazarus, R Thadhani New England Journal of Medicine 349 (5), 446-456, 2003 | 1256 | 2003 |
| Fibroblast growth factor 23 and risks of mortality and end-stage renal disease in patients with chronic kidney disease T Isakova, H Xie, W Yang, D Xie, AH Anderson, J Scialla, P Wahl, ... Jama 305 (23), 2432-2439, 2011 | 1215 | 2011 |
| Fibroblast growth factor-23 mitigates hyperphosphatemia but accentuates calcitriol deficiency in chronic kidney disease O Gutierrez, T Isakova, E Rhee, A Shah, J Holmes, G Collerone, H Ju, ... Journal of the American Society of Nephrology 16 (7), 2205-2215, 2005 | 1210 | 2005 |
| Fibroblast growth factor 23 and left ventricular hypertrophy in chronic kidney disease OM Gutiérrez, JL Januzzi, T Isakova, K Laliberte, K Smith, G Collerone, ... Circulation 119 (19), 2545-2552, 2009 | 1089 | 2009 |
| Vitamin D levels and early mortality among incident hemodialysis patients M Wolf, A Shah, O Gutierrez, E Ankers, M Monroy, H Tamez, D Steele, ... Kidney international 72 (8), 1004-1013, 2007 | 1075 | 2007 |
| Activated injectable vitamin D and hemodialysis survival: a historical cohort study M Teng, M Wolf, MN Ofsthun, JM Lazarus, MA Hernán, CA Camargo Jr, ... Journal of the American Society of Nephrology 16 (4), 1115-1125, 2005 | 1052 | 2005 |
| Adiposity, cardiometabolic risk, and vitamin D status: the Framingham Heart Study S Cheng, JM Massaro, CS Fox, MG Larson, MJ Keyes, EL McCabe, ... Diabetes 59 (1), 242-248, 2010 | 736 | 2010 |
| Effects of phosphate binders in moderate CKD GA Block, DC Wheeler, MS Persky, B Kestenbaum, M Ketteler, ... Journal of the American Society of Nephrology 23 (8), 1407-1415, 2012 | 667 | 2012 |
| First trimester placental growth factor and soluble fms-like tyrosine kinase 1 and risk for preeclampsia R Thadhani, WP Mutter, M Wolf, RJ Levine, RN Taylor, VP Sukhatme, ... The Journal of Clinical Endocrinology & Metabolism 89 (2), 770-775, 2004 | 639 | 2004 |
| Activation of cardiac fibroblast growth factor receptor 4 causes left ventricular hypertrophy A Grabner, AP Amaral, K Schramm, S Singh, A Sloan, C Yanucil, J Li, ... Cell metabolism 22 (6), 1020-1032, 2015 | 592 | 2015 |
| Fibroblast growth factor-23 and cardiovascular events in CKD JJ Scialla, H Xie, M Rahman, AH Anderson, T Isakova, A Ojo, X Zhang, ... Journal of the American Society of Nephrology 25 (2), 349-360, 2014 | 550 | 2014 |
| Inflammation and functional iron deficiency regulate fibroblast growth factor 23 production V David, A Martin, T Isakova, C Spaulding, L Qi, V Ramirez, ... Kidney international 89 (1), 135-146, 2016 | 497 | 2016 |
| Update on fibroblast growth factor 23 in chronic kidney disease M Wolf Kidney international 82 (7), 737-747, 2012 | 492 | 2012 |
| Calciphylaxis from nonuremic causes: a systematic review SU Nigwekar, M Wolf, RH Sterns, JK Hix Clinical Journal of the American Society of Nephrology 3 (4), 1139-1143, 2008 | 491 | 2008 |
